IRIS
Ingrasciotta, Ylenia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 951
EU - Europa 868
AS - Asia 252
Totale 2.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 950
IE - Irlanda 320
SE - Svezia 245
IT - Italia 136
VN - Vietnam 106
CN - Cina 99
PL - Polonia 66
DE - Germania 44
SG - Singapore 29
RO - Romania 15
IN - India 13
FI - Finlandia 11
BE - Belgio 9
NL - Olanda 7
FR - Francia 4
GB - Regno Unito 4
UA - Ucraina 4
CZ - Repubblica Ceca 2
ES - Italia 1
JM - Giamaica 1
KR - Corea 1
MY - Malesia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.071
Salva come PNG Salva come JPEG
Città #
Chandler 324
Dublin 320
Nyköping 140
Ashburn 109
Dong Ket 106
Warsaw 66
Messina 64
Princeton 51
Medford 42
Beijing 33
Ann Arbor 32
Bremen 30
Des Moines 25
Singapore 19
Jacksonville 17
New York 17
Boardman 15
Focsani 15
Rome 13
Washington 11
Cambridge 10
Dearborn 10
Frankfurt am Main 10
Brussels 9
Tianjin 9
Wilmington 9
Falls Church 8
Pune 7
Milan 6
Ningbo 6
Caltagirone 5
Shenyang 5
Jinan 4
Nanjing 4
Taizhou 4
Guangzhou 3
Haikou 3
Hyderabad 3
Jiaxing 3
Lancaster 3
Los Angeles 3
Nanchang 3
Redwood City 3
Salerno 3
Seattle 3
Zhengzhou 3
Amsterdam 2
Breganze 2
Brno 2
Chengdu 2
Erbè 2
Fairfield 2
Fremont 2
Fuzhou 2
Heidelberg 2
Helsinki 2
Houston 2
Lanzhou 2
Misterbianco 2
Palermo 2
San Mateo 2
Venaria Reale 2
Alexandria 1
Bari 1
Catania 1
College Station 1
Cormano 1
Cosenza 1
Dalian 1
Durham 1
Gioia del Colle 1
Hamburg 1
Hangzhou 1
Hebei 1
Hefei 1
Kiev 1
Kingston 1
Lappeenranta 1
Liverpool 1
Lviv 1
Madrid 1
Mumbai 1
Mykolayiv 1
Pavia 1
Poltava 1
Poona 1
Puchong Batu Dua Belas 1
Seoul 1
Strasbourg 1
Taipei 1
Trieste 1
Vittoria 1
Woodbridge 1
Wuhan 1
Totale 1.652
Salva come PNG Salva come JPEG
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 143
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 101
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 86
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 80
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 72
Psoriasis and psoriasiform reactions secondary to Immune Checkpoint Inhibitors 68
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 65
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 65
Analgesic drug use in elderly persons: A population-based study in Southern Italy 64
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 59
Medication is an additional source of phosphate intake in chronic kidney disease patients 56
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 53
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy 51
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 48
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014 47
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 47
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 45
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 43
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 43
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013 42
Biosimilars in Italy: What do real-world data reveal? 42
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset 41
Recent advances in the management of chemotherapy-induced neutropenia: Biosimilar granulocyte colony-stimulating factor use in Italy 41
Real world use of antidiabetic drugs in the years 2011–2017: A population-based study from Southern Italy 40
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy 39
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 39
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 38
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease 38
null 37
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 37
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 37
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 36
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies 35
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0) 34
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries 34
Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments 33
Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013 31
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials 30
null 28
The advent of biosimilars for the treatment of diabetes: current status and future directions 26
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction. 25
null 24
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 22
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence. 21
null 19
null 18
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 18
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo 17
null 17
Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients 14
Hidradenitis suppurativa and psoriasis: the odd couple 6
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context 6
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review 3
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 1
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 1
Totale 2.206
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 1 0 2 1 10 3 4 2 22 10 44
2020/2021355 6 8 50 42 30 10 19 20 34 28 1 107
2021/2022380 2 23 2 4 16 8 46 5 24 83 33 134
2022/2023945 71 107 37 89 79 94 14 37 378 5 24 10
2023/2024292 17 30 27 31 30 93 15 5 3 14 1 26
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 2.206